Texas Original Releases Fast-Acting Sweet Dreams CBN Sleep Gummy

Texas Original, announced its Sweet Dreams gummies are now available to qualifying patients statewide. Sweet Dreams gummies are specifically designed to help qualifying patients who suffer from insomnia, night terrors or restlessness as a result of various medical conditions.

Patients can access the Sweet Dreams gummies from any of Texas Original’s 11 pickup locations and two permanent locations statewide.

“When I sit down with patients to learn about their experiences with medical cannabis, I am overwhelmed by the relief they find from pain, insomnia and so many other symptoms that take a daily toll on their lives,” stated Morris Denton, CEO of Texas Original. “With Sweet Dreams, we can specifically target one of the most essential parts of healing—a good night’s sleep. We’ve meticulously researched and tested these gummies to ensure patients get a consistent experience every time. They can rely on us to deliver the highest quality product on the market.”

The dewberry-flavored Sweet Dreams gummies are available in 30-count packages formulated with 5 mg of CBN, 10 mg of THC and targeted rest terpenes in each gummy. Featuring nanoemulsion technology, Sweet Dreams are fast-acting CBN-based gummies. Patients can expect to feel the initial treatment effects as soon as 15 minutes after consumption.

Photo: Courtesy of Business Wire

Related News

Texas Original Opens Frisco's First Medical Cannabis Pickup Location

Kelly Roland Promoted To President Of Texas Original

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsMarketsMorris DentonTexas OriginalTXOG
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
CCC-Oct-24-Banner-1

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.